THE EUROPEAN Medicines Agency (EMEA) has released a guideline on scientific requirements for the environmental risk assessment of gene therapy medicinal products - http://emea.europa.eu/pdfs/human/genetherapy/12549106enfin.pdf;
*It has recommended measures to manage contamination of heparin-containing medicines - http://emea.europa.eu/humandocs/PDFs/EPAR/heparin/27772208en.pdf;
*EMEA has also published a guideline on manufacturing human cell-based medicinal products - ...

Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.